Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Allos Therapeutics Appoints David M. Stout to Its Board of Directors
Allos Therapeutics, 03/25/09
Allos Therapeutics, Inc. , a biopharmaceutical company focused on developing and commercializing innovative new drugs for the treatment of cancer, announced the appointment of David M. Stout, former President, Pharmaceuticals at GlaxoSmithKline, to the Company’s Board of Directors.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
ImmunoGen, Inc., 12/18/09
CCHIT Appoints Officers
HealthDataManagement, 12/18/09
Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
Boston Scientific, 12/17/09
Article Search
Sponsor